Estimated geographical and temporal distribution of lung-cancer incidence varied across the four main subtypes worldwide. Our ...

Since the first, seminal randomised controlled trial (RCT) in inflammatory bowel disease (IBD) in 1955,1 the central tenets ...

All physicians are faced with the challenge of how to help patients with no approved therapies for their diseases. What are ...

The global incidence of cancer reached 20 million in 2022 and is projected to rise to 33·1 million by 2050.1 Amid the growing ...

A 58-year-old male patient presented to the dermatology clinic at West China Hospital of Sichuan University (Chengdu, Sichuan ...

We read with interest the article by Marie Lund and colleagues published in The Lancet Oncology investigating the association ...

Existing treatment criteria for chronic hepatitis B virus (HBV) infection are mainly based on data from observational studies, such as the REVEAL study from Taiwan, which was initiated in the early ...

Exposure to adverse childhood experiences (ACEs), including abuse, neglect, and household challenges, have harmful implications for long-term health and mental health outcomes.1 Indeed, ACEs are one ...

The phase 2 REST trial by Frida Bugge Askeland and colleagues, reported in The Lancet Haematology, provides insight into ...

In January, 2025, six wildfires broke out and spread rapidly across the greater Los Angeles region in California, USA. Fanned by the strong Santa Ana winds, these raging infernos have caused ...

Believers in haematological destiny would be intrigued to know that Cristóbal Frutos was born on May 28, which is World Blood Cancer Day. Still a few years younger than 40 years, he is the transplant ...

The International Agency for Research on Cancer predicts more than 35 million new cancer cases in 2050, a 77% increase from 2022. The greatest burden will fall on low-income and middle-income ...